FAIR-HF2 Trial: Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure
Stefan D. Anker, MD, PhD
Mahir Karakas, MD, PhD, MBA
Don't Miss It! Rapid & Accurate AAV Diagnosis
Silke R. Brix, MD, MRCP, SCPR
Andreas Kronbichler, MD
Optimizing AAV Outcomes: Maintenance Therapies
Bernhard Hellmich, MD
Preserving Renal Function in AAV: From Novel Therapies to Practice-Changing Strategies
June 06, 2025
Vienna
Elevating Care for Patients With Severe Renal Disease in AAV
Pearls of Wisdom: Optimizing Hyperkalemia Management in Patients with CKD
Matthew R. Weir, MD
Nihar Desai, MD
Ellie Kelepouris, MD, FACP, FAHA
No Patient Left Behind! Advancing CKD-Associated Pruritus Care
Kieran McCafferty, MD
Maurizio Gallieni, MD
Unmasking IgAN: From Suspicion to Timely Diagnosis
Jörg Latus, MD
Chee Kay Cheung, MBCHB, MRCP, PHD
Optimizing Outcomes in Patients With IgAN: Novel Therapies and Evolving Guidelines
Jürgen Floege, MD
Jonathan Barratt, PhD
Partnering for Progress: A Case Study in Patient-Centered Hyperkalemia Management
David Wheeler, MB, CHB, MD, FRCP
Call to Action: Utilizing Avacopan to Improve AAV Care
Stephen McAdoo, MD
Improving CKD Patient Outcomes with SGLT2 Inhibitors
Gates B. Colbert, MD
Incorporating Targeted Therapies in Treatment Planning for AAV
David Jayne, MD
Can We Do Better in IgAN?
Annette Bruchfeld, MD, PhD
Understanding IgAN & FSGS: Pathophysiology and Emerging Therapies
Donald E. Kohan, MD, PhD
Separating Fact from Fiction: The Realities of CKD-aP
Carol Pollock, AO, MBBS, PhD, FRACP, FAHMS
Antoine Lanot, MD, PhD
Loading...
NEW FEATURES:
Tell us what you think by using our Feedback button
We're glad to see you're enjoying Global Kidney Academy… but how about a more personalized experience?
Press cancel to remain on Global Kidney Academy. Press the link below or the continue button to keep going.